Machine learning based prediction of warfarin optimal dosing for African American patients
暂无分享,去创建一个
Houshang Darabi | Ashkan Sharabiani | Katarzyna Drozda | Adam Bress | Larisa Cavallari | Edith Nutescu | H. Darabi | L. Cavallari | A. Bress | E. Nutescu | K. Drozda | Ashkan Sharabiani
[1] Panos Deloukas,et al. Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans , 2012, Pharmacogenetics and genomics.
[2] W S McCulloch,et al. A logical calculus of the ideas immanent in nervous activity , 1990, The Philosophy of Artificial Intelligence.
[3] Wei Qu,et al. A motion trajectory based video retrieval system using parallel adaptive self organizing maps , 2005, Proceedings. 2005 IEEE International Joint Conference on Neural Networks, 2005..
[4] R. Beyth,et al. Major bleeding after hospitalization for deep-venous thrombosis. , 1999, The American journal of medicine.
[5] C. Keenan,et al. Effects of race and ethnicity on the incidence of venous thromboembolism. , 2009, Thrombosis research.
[6] Gordon H. Guyatt,et al. Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis , 2011 .
[7] Kurt Hornik,et al. Support Vector Machines in R , 2006 .
[8] M. Rieder,et al. Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin , 2008, Clinical pharmacology and therapeutics.
[9] L. Cavallari,et al. Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism , 2012, Clinical pharmacology and therapeutics.
[10] M. Gordon,et al. Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data , 2009 .
[11] Susan Regan,et al. Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation , 2007, Circulation.
[12] E. Capaldi,et al. The organization of behavior. , 1992, Journal of applied behavior analysis.
[13] Lutz Hamel,et al. Knowledge Discovery with Support Vector Machines , 2009 .
[14] Edith Nutescu,et al. Pharmacogenomics of warfarin dose requirements in Hispanics. , 2011, Blood cells, molecules & diseases.
[15] Yuchiao Chang,et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.
[16] Jason C. Fish,et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.
[17] Dona Schneider,et al. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. , 2006, Journal of the National Medical Association.
[18] C. Richards,et al. Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.
[19] Daniel Graupe,et al. Principles of Artificial Neural Networks , 2018, Advanced Series in Circuits and Systems.
[20] Larisa H Cavallari,et al. Factors influencing warfarin dose requirements in African-Americans. , 2007, Pharmacogenomics.
[21] Vladimir Vapnik,et al. Statistical learning theory , 1998 .
[22] Adam Bress,et al. Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans. , 2012, Pharmacogenomics.